14th March, 2023

Launch of Teicoplanin 200mg & 400mg IV Vials


Bowmed Ibisqus is pleased to announce the launch of our Teicoplanin IV Vials distributed in strengths of 200mg and 400mg.

Teicoplanin is a glycopeptide antibiotic with bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. Around 2 million doses of this product are administered in the UK each year and our launch will further reinforce the UK supply chain for this essential medicine.

The new products have been listed with AAH under codes TEI0008S (200mg) & TEI0007W (400mg). Stock is available for customers effective immediately.

If you would like to discuss a pricing arrangement or stock availability for Teicoplanin or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us

 
 
 
15th February, 2023

Launch of Ready to Administer IV Levofloxacin 500mg/100ml Bag


Bowmed Ibisqus is pleased to announce the launch of a Ready to Administer Levofloxacin Bag.  The product is a standard 500mg/100ml dose presented in a 10 pack and customers may prefer this more convenient dose form and the benefits it brings regarding reduction in glass waste.  The bag is packaged with a foil overwrap to protect the product from light and the overwrap clearly displays the essential product information.

This new product line has been listed with AAH under code LEV0316T and stock is available for customers effective immediately.

Our original product format, Levofloxacin 500mg/100ml Vial x 1pk, will continue to be available via usual supply routes and this may be preferred by hospitals with a lower demand for the product.  This product contains a hanger label and is therefore also Ready to Administer.

If you would like to discuss a pricing arrangement or stock availability for Levofloxacin Bags or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us